文献速递主动脉疾病

择期胸主动脉腔内修复术后一年主要不良心血管事件的预测因素:单中心回顾性研究

Predictors of One-Year Major Adverse Cardiovascular Events following Elective Thoracic Endovascular Aortic Repair: A Single-center Retrospective Study.
PubMed 文献 · Ann Vasc Surg · 2025-07-18

该单中心回顾性研究纳入41例择期TEVAR的退行性降主动脉瘤患者,评估术前及围术期因素对1年MACE的影响。1年死亡率和MACE率分别为22.0%和24.4%,降主动脉直径较大是1年MACE的独立预测因素(OR 1.1,95%CI 1.0-1.2,P=0.013)。

要点

  • 择期TEVAR术后1年MACE率为24.4%,死亡率22.0%。
  • 发生MACE者降主动脉直径更大(74.2±24.7 vs 51.7±17.4 mm,P=0.003)。
  • 降主动脉直径是1年MACE独立预测因素(OR 1.1,95%CI 1.0-1.2)。

核心结论

  • 较大的降主动脉直径是择期TEVAR术后1年MACE的独立预测因素。
  • 术前风险评估应纳入降主动脉直径等参数以优化患者选择。

研究设计与样本

  • 排除急诊或紧急指征及既往主动脉手术史患者,采用逻辑回归分析预测因素。

主要发现

  • 30天死亡率和MACE率分别为4.9%(n=2)和7.3%(n=3)。
  • 1年死亡率和MACE率分别为22.0%(n=9)和24.4%(n=10)。
  • 发生1年MACE者降主动脉直径显著更大(74.2±24.7 mm vs 51.7±17.4 mm;P=0.003)。
  • 发生1年MACE者术前血红蛋白水平更低(11.4±2.0 g/dL vs 13.2±2.2 g/dL;P=0.036)。
  • 多变量分析显示降主动脉直径为1年MACE独立预测因素(OR 1.1;95%CI 1.0-1.2;P=0.013)。

临床怎么用

  • 术前应测量降主动脉直径,对直径较大者加强风险评估与术后监测。
  • 关注术前血红蛋白水平,低血红蛋白患者可能需优化围术期管理。

局限性

  • 单中心回顾性设计,样本量小(41例),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elective thoracic endovascular aortic repair (TEVAR) is a widely adopted intervention for descending thoracic aortic aneurysms. Over recent years, this endovascular technique has surpassed open surgery due to its reduced complications and mortality rates. However, certain preoperative and periprocedural clinical and analytical factors may significantly impact 1-year mortality and the incidence of major adverse cardiovascular events (MACE) in patients. Identifying these predictors is essential for optimizing patient selection and improving postoperative outcomes. This study aims to evaluate the impact of these factors on 1-year MACE following elective TEVAR. METHODS: This retrospective, single-centre study included 41 patients with degenerative descending thoracic aneurysm who underwent elective TEVAR between January 2010 and December 2023. Procedures with emergent or urgent indications and patients with a prior history of aortic surgical intervention were excluded. Preoperative variables, including baseline comorbidities, laboratory values, anatomical characteristics, and procedure-specific planning details, were recorded. The primary end point was MACE at 1-year after TEVAR. MACE included acute myocardial infarction, cardiorespiratory arrest, stroke, or death. Logistic regression analysis was used to identify predictors of 1-year MACE. RESULTS: The study cohort included 41 patients (80.5% male) with a mean age of 70.2 ± 10.5 years. The 30-day mortality and MACE rates were 4.9% (n = 2) and 7.3% (n = 3), respectively. At 1 year, the mortality and MACE rates were 22.0% (n = 9) and 24.4% (n = 10), respectively. Patients who experienced MACE at 1 year had a significantly larger descending aorta diameter (74.2 ± 24.7 mm vs. 51.7 ± 17.4 mm; P = 0.003) and lower preoperative hemoglobin levels (11.4 ± 2.0 g/dL vs. 13.2 ± 2.2 g/dL; P = 0.036) compared to those without MACE. Multivariable analysis identified descending aortic diameter as an independent predictor of 1-year MACE (odds ratio 1.1; 95% confidence interval, 1.0-1.2; P = 0.013). CONCLUSION: Larger descending aortic diameter was an independent predictor of 1-year MACE post-TEVAR. These findings underscore the critical importance of incorporating these parameters into preoperative risk stratification to optimize patient selection and improve long-term outcomes. By emphasizing careful preoperative assessment, we can enhance patient safety and surgical success, ultimately guiding clinical decision-making toward more personalized and effective therapeutic strategies.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cardoso S, Calisto T, Pinelo A, et al. Predictors of One-Year Major Adverse Cardiovascular Events following Elective Thoracic Endovascular Aortic Repair: A Single-center Retrospective Study. Ann Vasc Surg. 2025. PMID: 40685074. doi:10.1016/j.avsg.2025.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。